Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 4, 2021Journal of Clinical OncologyOpen Access

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMatteo BersanelliHumanitas UniversityETErica TravaglinoUniversity of PaviaMMManja MeggendorferMunich Leukemia Laboratory (Germany)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bersanelli et al. (2021) studied this question.

synapsesocial.com/papers/6a12e94af7bd4f5c7da71435https://doi.org/10.1200/jco.20.01659
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS1996 · 10,022 citations
  2. 2Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making2005 · 865 citations
  3. 3Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes2013 · 431 citations
  4. 4TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups2019 · 266 citations
  5. 5Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation2017 · 790 citations